EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Research progress of drug-induced osteoporosis

Wenbin Tan, Ting He, Jia Li

Osteoporosis International · 2026

DOI: 10.1007/s00198-026-07941-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Osteoporosis International, 2026. Verfasst von Wenbin Tan und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China. Hauptthemen laut MEDLINE: Osteoporosis. Die Arbeit nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-induced osteoporosis (DIO) is an important part of secondary osteoporosis. This article discusses the effects of common drugs on bone metabolism and the possible mechanisms leading to osteoporosis and discusses the possible treatment strategies. Although anti-osteoporosis drugs can effectively improve bone mineral density and reduce the risk of fracture and prevent the occurrence of DIO, long-term use of anti-osteoporosis drugs may lead to skeletal adverse events such as atypical femur fracture. Therefore, for the prevention and treatment of DIO, the benefits and adverse reactions of drugs should be comprehensively considered to develop an individualized treatment plan for patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisHumansBone Density Conservation AgentsAntineoplastic AgentsAntidepressive AgentsBone DensityOsteoporotic FracturesGlucocorticoidsAnalgesics, Opioid

Stichwörter der Autor:innen

5-α reductase inhibitorAntidepressant drugsAntineoplastic drugsGlucocorticoidsLevothyroxineOpioidsProton pump inhibitorsSecondary osteoporosis

Substanzen

Bone Density Conservation AgentsAntineoplastic AgentsAntidepressive AgentsGlucocorticoidsAnalgesics, Opioid

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Department of Endocrinology, General Hospital of Southern Theater Command, PLA, Guangzhou, China.
  • The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China. gdnflj@smu.edu.cn.
  • Department of Endocrinology, General Hospital of Southern Theater Command, PLA, Guangzhou, China. gdnflj@smu.edu.cn.
  • Graduate School of Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510006, China. gdnflj@smu.edu.cn.

Zitieren

APA

Tan, W., He, T., & Li, J. (2026). Research progress of drug-induced osteoporosis. Osteoporosis International. https://doi.org/10.1007/s00198-026-07941-7

Vancouver

Tan W, He T, Li J. Research progress of drug-induced osteoporosis. Osteoporosis International. 2026. doi:10.1007/s00198-026-07941-7

BibTeX
@article{Tan2026,
  author = {Tan, Wenbin and He, Ting and Li, Jia},
  title = {Research progress of drug-induced osteoporosis},
  journal = {Osteoporosis International},
  year = {2026},
  doi = {10.1007/s00198-026-07941-7}
}
Kostenlos starten →